These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
234 related items for PubMed ID: 18609087
1. Prognostic significance of hepatocyte growth factor and microvessel bone marrow density in patients with chronic myeloid leukaemia. Zhelyazkova AG, Tonchev AB, Kolova P, Ivanova L, Gercheva L. Scand J Clin Lab Invest; 2008; 68(6):492-500. PubMed ID: 18609087 [Abstract] [Full Text] [Related]
2. [Study on the role of angiogenesis and related factors in leukemias]. Zhang Y, Gu J, Wang M, Ma L, Wang XL, He B, Sun M. Zhonghua Xue Ye Xue Za Zhi; 2005 Mar; 26(3):175-8. PubMed ID: 15946533 [Abstract] [Full Text] [Related]
3. Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma. Pappa CA, Tsirakis G, Kanellou P, Kaparou M, Stratinaki M, Xekalou A, Alegakis A, Boula A, Stathopoulos EN, Alexandrakis MG. Cytokine; 2011 Dec; 56(3):616-20. PubMed ID: 21940178 [Abstract] [Full Text] [Related]
4. [Correlation of angiogenesis with expression of vascular endothelial growth factor and its receptors in lung carcinoma]. Zhang G, Zhao M, Xu M, Yang Y, Wang M, Yang C. Zhonghua Jie He He Hu Xi Za Zhi; 2002 Feb; 25(2):89-93. PubMed ID: 11953105 [Abstract] [Full Text] [Related]
7. Clinicopathologic correlations of bone marrow angiogenesis in chronic myeloid leukemia: a morphometric study. Korkolopoulou P, Viniou N, Kavantzas N, Patsouris E, Thymara I, Pavlopoulos PM, Terpos E, Stamatopoulos K, Plata E, Anargyrou K, Androulaki A, Davaris P, Yataganas X. Leukemia; 2003 Jan; 17(1):89-97. PubMed ID: 12529665 [Abstract] [Full Text] [Related]
8. [Dynamic observation of vascular endothelial growth factor (VEGF)/VEGF-receptors expression in acute leukemia]. Wang C, Chen FY, Zhu JS, Xu YP, Han JY, Ouyang RR. Zhonghua Nei Ke Za Zhi; 2004 Nov; 43(11):845-8. PubMed ID: 15634546 [Abstract] [Full Text] [Related]
9. Syndecan-1 and angiogenic cytokines in multiple myeloma: correlation with bone marrow angiogenesis and survival. Andersen NF, Standal T, Nielsen JL, Heickendorff L, Borset M, Sørensen FB, Abildgaard N. Br J Haematol; 2005 Jan; 128(2):210-7. PubMed ID: 15638855 [Abstract] [Full Text] [Related]
10. [Angiogenesis in different clinical phases of chronic myeloid leukemia]. Krasowska-Kwiecień A, Kijowski J, Łukasiewicz E, Sacha T, Foryciarz K, Majka M, Ratajczak MZ, Skotnicki AB. Przegl Lek; 2009 Jan; 66(9):471-8. PubMed ID: 21033405 [Abstract] [Full Text] [Related]
11. Prognostic significance of vascular endothelial growth factor immunoexpression in the context of adverse standard prognostic factors in multiple myeloma. Ribas C, Colleoni GW, Silva MR, Carregoza MJ, Bordin JO. Eur J Haematol; 2004 Nov; 73(5):311-7. PubMed ID: 15458509 [Abstract] [Full Text] [Related]
12. Immunohistochemical detection of VEGF in the bone marrow of patients with chronic myeloid leukemia and correlation with the phase of disease. Krauth MT, Simonitsch I, Aichberger KJ, Mayerhofer M, Sperr WR, Sillaber C, Schneeweiss B, Mann G, Gadner H, Valent P. Am J Clin Pathol; 2004 Apr; 121(4):473-81. PubMed ID: 15080298 [Abstract] [Full Text] [Related]
13. Regulation of angiogenesis in the bone marrow of myelodysplastic syndromes transforming to overt leukaemia. Keith T, Araki Y, Ohyagi M, Hasegawa M, Yamamoto K, Kurata M, Nakagawa Y, Suzuki K, Kitagawa M. Br J Haematol; 2007 May; 137(3):206-15. PubMed ID: 17408459 [Abstract] [Full Text] [Related]
14. Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity. Lashkari K, Hirose T, Yazdany J, McMeel JW, Kazlauskas A, Rahimi N. Am J Pathol; 2000 Apr; 156(4):1337-44. PubMed ID: 10751359 [Abstract] [Full Text] [Related]
15. [Expression of hepatocyte growth factor, transcription factor SP1, vascular endothelial growth factor and CD34 in serosa-infiltrative gastric cancer and their relations with defluxion of gastric cancer cell and prognosis]. Li CF, Wei YZ, Xue YW. Zhonghua Wai Ke Za Zhi; 2009 Feb 01; 47(3):206-9. PubMed ID: 19563076 [Abstract] [Full Text] [Related]
16. [Bone marrow microvessel density and vascular endothelial growth factor expression in patients with aplastic anemia]. Zhang L, Wang HJ, Li HQ, Yang DL, Yan ZS, Wu YH, Zhou K, Chu YL, Chen HS, Zhang FK. Zhonghua Xue Ye Xue Za Zhi; 2007 Aug 01; 28(8):528-31. PubMed ID: 18078128 [Abstract] [Full Text] [Related]
17. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model. Nakabayashi M, Morishita R, Nakagami H, Kuba K, Matsumoto K, Nakamura T, Tano Y, Kaneda Y. Diabetologia; 2003 Jan 01; 46(1):115-23. PubMed ID: 12637990 [Abstract] [Full Text] [Related]
18. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival. Decaussin M, Sartelet H, Robert C, Moro D, Claraz C, Brambilla C, Brambilla E. J Pathol; 1999 Aug 01; 188(4):369-77. PubMed ID: 10440746 [Abstract] [Full Text] [Related]
19. [The expression of hepatocyte growth factor and its receptor in brain astrocytomas]. Chu SH, Yuan XH, Jiang PC, Li ZQ, Zhang J, Wen ZH, Zhao SY, Chen XJ, Cao CJ. Zhonghua Yi Xue Za Zhi; 2005 Mar 30; 85(12):835-8. PubMed ID: 15949402 [Abstract] [Full Text] [Related]
20. Immunohistochemical analysis of hepatocyte growth factor and c-Met in plasma cell disease. Wader KF, Fagerli UM, Børset M, Lydersen S, Hov H, Sundan A, Bofin A, Waage A. Histopathology; 2012 Feb 30; 60(3):443-51. PubMed ID: 22276607 [Abstract] [Full Text] [Related] Page: [Next] [New Search]